Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
about
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisInhaled corticosteroids for stable chronic obstructive pulmonary diseaseInhaled corticosteroids for stable chronic obstructive pulmonary diseaseIdentification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysisThe asthma-COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary diseaseA re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary diseasePharmacological strategies to reduce exacerbation risk in COPD: a narrative reviewGlucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary diseaseCough and its importance in COPDSputum proteomics in inflammatory and suppurative respiratory diseasesSputum myeloperoxidase in chronic obstructive pulmonary disease.Blood and sputum eosinophils in COPD; relationship with bacterial load.Asthma and chronic obstructive pulmonary diseaseAirways disease: phenotyping heterogeneity using measures of airway inflammation.COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils.Reference ranges for induced sputum eosinophil counts in Korean adult population.Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.Immunological Features of Chronic Obstructive Pulmonary Disease (COPD) Induced by Indoor Pollution and Cigarette SmokeAssessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPDExpression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD.Repeatability of exhaled nitric oxide measurements in patients with COPDNovel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease.Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?The role of CT scanning in multidimensional phenotyping of COPD.Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia.Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled TrialSputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma.The effects of corticosteroids on COPD lung macrophages: a pooled analysisIs a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?Inflammatory cells in the airways in COPD.COPD: it is time to change!Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial.Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients.Pulmonary biomarkers in chronic obstructive pulmonary disease.Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional studyA challenge to the seven widely believed concepts of COPD.Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.
P2860
Q24197853-5950E44D-92DB-4821-BFAA-76FAD0C6F56DQ24202092-21735712-525A-4825-B4A6-B0796B81BCC9Q24245481-B0450405-E3C2-4E2D-9731-191F50262824Q24658537-97F02113-E58D-4F1C-B81D-8800F8F89CCCQ26745760-963473EB-0F8F-4AD2-B76D-0CBB25E96BC6Q26771819-61275275-61C5-47AC-A2A9-54C089C503B9Q26801661-5ACB139E-C7F9-4C18-B813-63418553F682Q28070274-EB97268B-ED38-4B39-9C55-3449DED2D1C7Q28761895-E02AB352-3B63-469D-A487-5467833F014FQ30488037-9A482E96-09C3-4CFB-BC50-9468C52BEDD0Q33345110-8A01F006-041E-4655-9ED4-5E74536899ADQ33592946-A45C38FD-4351-4320-ADB6-25E10BA6C0B8Q33651114-058536F7-1C9E-4E66-9A36-CC654C9928BCQ33706788-6D323E1E-B056-4C9F-807A-296187CD05C2Q33864952-0397618B-1BC9-47D5-AF3E-83011A020CF4Q33970269-74FAA9CC-32B5-40A5-BE18-DFBB6C27DAD0Q33974508-67B33ED2-E398-4E04-8970-2809C25AE12AQ34065276-AA03CBC4-2C60-42BF-9E51-21FA8D5BB774Q34126693-7AC39858-189D-4CCD-A35D-F920AB268B7DQ34231310-371B3DF0-84D2-4584-9432-4519A41786F5Q34275321-292135CD-0175-4CC4-9309-F34356E2E24DQ34619392-CD73B7D7-3671-4205-A91E-2F6990DF6352Q34684239-D6DDBBD6-1660-4CBB-8002-6D72494B4F89Q34808077-6F97C03C-5411-4DC3-B0CD-418B083501D6Q35041299-9C87B7B3-0B30-45DD-AB4A-E8A0155395B7Q35119108-71BBC6BF-BDDB-409E-9DF0-522A04E4B72AQ35201868-F094E1AE-BC0B-4A8F-8E26-A33A6C8030B1Q35675040-CC2806CA-D6E8-44A2-9449-822CC13F6CEFQ35867300-B7FBAFCD-B03E-42CA-A29E-44D64AF9A919Q35940249-32042A93-DF51-4379-BA5A-07812BF0C24FQ35985973-EA07FF4C-ED56-43CA-8F9C-B82DA4BF14B3Q36036910-CED1A0A0-F37C-4FD8-924F-AF6B9AC34D36Q36203075-39CE8043-9B3F-4876-9F0F-0A3644482A9CQ36288971-74A80545-F772-4CB1-A26B-7AD8F5D7E7BEQ36302882-15FCD250-245E-4BF6-A299-AEF3E09A7E3FQ36412702-0CBA871E-360A-4A5E-92E3-36BA52D4161EQ36429908-FB554E7A-186B-4684-BE7E-74A7E699B79CQ36444783-FC87DA4E-8D7C-420A-948A-C63BBFBC67E0Q36558218-4F7614F3-574F-483F-A477-9503C12B15A9Q36907742-948E0D93-B04A-4697-828D-084C449FB9B2
P2860
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Sputum eosinophilia and the sh ...... obstructive pulmonary disease.
@ast
Sputum eosinophilia and the sh ...... obstructive pulmonary disease.
@en
type
label
Sputum eosinophilia and the sh ...... obstructive pulmonary disease.
@ast
Sputum eosinophilia and the sh ...... obstructive pulmonary disease.
@en
prefLabel
Sputum eosinophilia and the sh ...... obstructive pulmonary disease.
@ast
Sputum eosinophilia and the sh ...... obstructive pulmonary disease.
@en
P2093
P2860
P50
P356
P1433
P1476
Sputum eosinophilia and the sh ...... obstructive pulmonary disease
@en
P2093
Hargadon B
Monteiro W
P2860
P304
P356
10.1136/THX.2004.032516
P407
P577
2005-03-01T00:00:00Z